GW PHARMACEUTICALS PLC Proceeds from Stock Options Exercised
GW PHARMACEUTICALS PLC reported Proceeds from Stock Options Exercised of $2.33 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-05-03
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for the quarter ending 2021-03-31 was $2.33M, a 77566.67% increase year-over-year.
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for the quarter ending 2020-12-31 was $2.00K.
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for the quarter ending 2020-09-30 was $1.57M.
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for the quarter ending 2020-06-30 was $2.00K, a 99.90% decline year-over-year.
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for fiscal 2020 was $1.58M, a 45.14% decline from fiscal 2019.
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for fiscal 2019 was $2.88M.
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for fiscal 2018 was $621.00K, a 409.02% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC proceeds from stock options exercised for fiscal 2017 was $122.00K, a 87.45% decline from fiscal 2016.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-03-31 | $2.33M 10-Q · filed 2021-05-03 | $2.33M derived: sum of 2 quarters · filed 2021-05-03 | $3.90M derived: sum of 3 quarters · filed 2021-05-03 | $3.91M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.57M derived: sum of 2 quarters · filed 2021-02-26 | $1.58M derived: sum of 3 quarters · filed 2021-02-26 | $1.58M 10-K · filed 2021-02-26 |
| 2020-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.57M derived: sum of 2 quarters · filed 2020-11-05 | $1.58M 10-Q · filed 2020-11-05 | $1.58M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $5.00K 10-Q · filed 2020-08-07 | $5.00K derived: sum of 3 quarters · filed 2021-05-03 | $5.00K derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $3.00K 10-Q · filed 2021-05-03 | $3.00K derived: sum of 2 quarters · filed 2021-05-03 | $3.00K derived: sum of 3 quarters · filed 2021-05-03 | $2.11M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $2.10M derived: sum of 3 quarters · filed 2021-02-26 | $2.88M 10-K · filed 2021-02-26 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.10M derived: sum of 2 quarters · filed 2020-11-05 | $2.88M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.88M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $773.00K 10-Q · filed 2020-05-11 | |||
| 2018-09-30 | $617.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $618.00K derived: sum of 2 quarters · filed 2019-11-06 | $619.00K 10-Q · filed 2019-11-06 | $621.00K 10-K · filed 2021-02-26 |
| 2018-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.00K 10-Q · filed 2019-08-07 | $3.00K derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | $1.00K 10-Q · filed 2019-05-08 | $2.00K derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | $1.00K 10-K · filed 2021-02-26 | |||
| 2017-09-30 | $122.00K 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $972.00K 10-KT · filed 2019-02-28 |